Reduced schedules of 4CMenB vaccine in infants and catch-up series in children: Immunogenicity and safety results from a randomised open-label phase 3b trial
Keywords: 4CMenB vaccination; Reduced doses; Catch-up dose; Infants; Children; AE; adverse event; CI; confidence interval; 4CMenB; multi-component vaccine against MenB; fHbp; factor H binding protein; GMT; geometric mean titers; hSBA; serum bactericidal assay with